DEGS2 and colorectal cancer: Recently, Guo and collaborators found the role of m6A modification on DEGS2 in colorectal cancer and suggested that inhibited m6A promotes DEGS2 expression and dysregulated lipid metabolites, contributing to colorectal cancer (Guo et al., 2021).